• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.98 Up 0.03(0.43%) 4:00PM EST
    |After Hours : 6.98 Down 0.00 (0.01%) 4:38PM EST
    Add to Portfolio
    Prev Close:6.95
    Open:6.96
    Bid:6.67 x 600
    Ask:N/A
    1y Target Est:7.50
    Beta:0.73
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:6.90 - 7.01
    52wk Range:6.52 - 10.26
    Volume:5,587,603
    Avg Vol (3m):2,920,470
    Market Cap:1.14B
    P/E (ttm):3.75
    EPS (ttm):1.86
    Div & Yield:0.60 (8.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 0.43%1.14B
    AMGNDown 0.79%119.69B
    SGENDown 0.49%4.49B
    XOMADown 3.66%396.28M

    Key Statistics

    Forward P/E (1 yr):8.84
    P/S (ttm):2.32
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.20
    Quarterly EPS Est (Mar-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback